VALEANT PHARMACEUTICALS v. ACTAVIS LABORATORIES FL., INC , No. 20-1201 (Fed. Cir. 2020)

Annotate this Case

Download PDF

Case: 20-1201 Document: 54 Page: 1 Filed: 12/18/2020 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ VALEANT PHARMACEUTICALS INTERNATIONAL, SALIX PHARMACEUTICALS LTD., COSMO TECHNOLOGIES LIMITED, Plaintiffs-Appellants v. ACTAVIS LABORATORIES FL., INC., ACTAVIS PHARMA, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees ______________________ 2020-1201 ______________________ Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-01288-LPS, Chief Judge Leonard P. Stark. ______________________ JUDGMENT ______________________ THOMAS P. STEINDLER, McDermott, Will & Emery LLP, Washington, DC, argued for all plaintiffs-appellants. Plaintiffs-appellants Valeant Pharmaceuticals International, Salix Pharmaceuticals Ltd. also represented by MICHAEL BRUNO, PAUL MICHAEL CHRISTOPHER Case: 20-1201 Document: 54 Page: 2 Filed: 12/18/2020 SCHOENHARD. GARY N. FRISCHLING, Milbank LLP, Los Angeles, CA, for plaintiff-appellant Cosmo Technologies Limited. Also represented by YITE JOHN LU. WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for defendants-appellees. Also represented by JOHN T. BENNETT, GERARD JUSTIN CEDRONE, SAMUEL SHERRY, Boston, MA; ELIZABETH HOLLAND, New York, NY. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (NEWMAN, DYK, and REYNA, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT December 18, 2020 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.